Suven Pharmaceuticals financials at a glance

+ Portfolio

The revenue of Suven Pharmaceuticals is reported as 13.40329 billion Rupees in the fiscal year 2024. The earnings were 16.16 Rupees per share in 2024, which was 9.37 lower than 2022. And about 4.50912 billion Rupees are reported as free cash flow in the financials of Suven Pharmaceuticals 2024. Dividends of 2.35 Rupees per share were paid to shareholders of Suven Pharmaceuticals stock NSEI:SUVENPHAR in fiscal 2024.

Rp13.40B

Revenue

Rp16.16

Earnings Per Share

56.32%

Gross Margin %

Rp1.65B

Free Cash Flow

Revenue

13,403.29

Earnings Per Share

16.16

Gross Margin %

56.32

Free Cash Flow

1,651.41

Financials

Year	Year	TTM	2023	2022	2021	2020
Rev.	Revenue	N/A	Rp13.40B	Rp13.20B	Rp10.10B	Rp0.00M
GM %	Gross Margin %	58.95%	56.32%	56.51%	56.70%	59.69%
OM	Operating Margin	40.87%	38.71%	41.03%	40.59%	43.36%
EPS	Earnings Per Share	Rp16.96	Rp16.16	Rp17.83	Rp14.23	Rp4.97
Div.	Dividends	N/A	Rp2.35	Rp2.00	Rp2.00	Rp0.00
PR %	Payout Ratio %	0	14.54%	11.22%	14.05%	0
Sha.	Shares	N/AM	254.56M	254.56M	254.56M	254.56M
OCF	Operating Cash Flow	N/A	Rp4.51B	Rp3.30B	Rp3.83B	Rp0.00M
FCF	Free Cash Flow	N/A	Rp1.65B	Rp2.55B	Rp720.40M	Rp0.00M
FCFS	Free Cash Flow Per Share	Rp12.29	Rp6.49	Rp10.01	Rp10.71	Rp12.43

Suven Pharmaceuticals financials at a glance

Financials

Discover